Avenue Therapeutics | IPO Presentation Deck | 30 slides · page 18 of 30
The chart shows BAER-101 regimens consistently resulting in lower sleepiness rates than Lorazepam.
Regulatory filing · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 chart 1/1 source-note 1/1 subtitle 1/1 title 1/1
Components 5
primary line source-note subtitle headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.